SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-052696
Filing Date
2020-04-29
Accepted
2020-04-29 06:13:35
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q uthr-20200331x10q.htm   iXBRL 10-Q 1889059
2 EXHIBIT 10.1 uthr-20200331xex10d1.htm EX-10.1 48129
3 EXHIBIT 31.1 uthr-20200331xex31d1.htm EX-31.1 16759
4 EXHIBIT 31.2 uthr-20200331xex31d2.htm EX-31.2 16888
5 EXHIBIT 32.1 uthr-20200331xex32d1.htm EX-32.1 10719
6 EXHIBIT 32.2 uthr-20200331xex32d2.htm EX-32.2 9903
  Complete submission text file 0001104659-20-052696.txt   8066338

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA uthr-20200331.xsd EX-101.SCH 55503
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE uthr-20200331_cal.xml EX-101.CAL 58693
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE uthr-20200331_def.xml EX-101.DEF 262816
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20200331_lab.xml EX-101.LAB 554184
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20200331_pre.xml EX-101.PRE 405139
42 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20200331x10q_htm.xml XML 1539717
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 20827179
SIC: 2834 Pharmaceutical Preparations